Cargando…
Efficacy and Tolerability of Pharmacotherapy Options for the Treatment of Medullary Thyroid Cancer
Metastatic and unresectable medullary thyroid carcinoma (MTC) is often difficult to treat as it is relatively unresponsive to radiation and conventional chemotherapy. This emphasizes the importance of the development of targeted therapies for advanced MTC. Vandetanib was approved by the US Food and...
Autores principales: | Deshpande, H. A., Sheth, K., Sosa, J. A., Roman, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489097/ https://www.ncbi.nlm.nih.gov/pubmed/23133319 http://dx.doi.org/10.4137/CMO.S8305 |
Ejemplares similares
-
Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
por: Degrauwe, Nils, et al.
Publicado: (2012) -
Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
por: Deshpande, Hari, et al.
Publicado: (2011) -
Efficacy and Tolerability of Pharmacotherapy Options for the Treatment of Irritability in Autistic Children
por: Kirino, Eiji
Publicado: (2014) -
Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer
por: Deshpande, Hari, et al.
Publicado: (2011) -
Treatment of advanced medullary thyroid cancer
por: Smit, Johannes
Publicado: (2013)